ImmuONE: Venture Capital Funding History

ImmuONE raises £600k follow-on from investors to expand 3D lung model as an alternative to animal testing

ImmuONE provides a 3D human lung laboratory model that replaces animal testing, allowing companies to assess respiratory safety, inflammation and long-term effects of chemicals, drugs and consumer products more reliably.